InSite HER2/neu Kit regulatory update

FDA approved a PMA for BioGenex's InSite HER2/neu Kit an in vitro diagnostic kit to identify breast cancer patients eligible for Herceptin trastuzumab treatment. The automated format of the kit is ap...